金斯瑞(01548.HK):传奇生物(LEGN.US)将于美国及欧洲披露CARVYKTI最新资料

阿斯达克财经
Yesterday

金斯瑞生物科技(01548.HK) 公布,其联营传奇生物(LEGN.US)  将于2025年美国临床肿瘤学会年会(ASCO)和欧洲血液学协会(EHA)大会上公布CARTITUDE临床开发项目最新资料,该项目评估用于治疗多发性骨髓瘤患者的CARVYKTI(西达基奥仑赛,简称cilta-cel)。(jl/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-22 16:25。) (美股为即时串流报价; OTC市场股票除外,资料延迟最少15分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10